FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/07/019961 [Registered on: 01/07/2019] Trial Registered Prospectively
Last Modified On: 27/06/2019
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   COMPARISON OF TAMSULOSIN AND SILODOSIN IN TREATMENT OF LOWER URETERIC STONES 
Scientific Title of Study   COMPARISON OF EFFICIENCY OF TAMSULOSIN VS SILODOSIN IN THE TREATMENT OF LOWER URETERIC CALCULUS-RANDOMISED CONTROLLED STUDY 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Arunchand R 
Designation  Junior Resident Surgery 
Affiliation  Armed Forces Medical College 
Address  Department of Surgery Armed Forces Medical College Pune Maharashtra

Pune
MAHARASHTRA
411040
India 
Phone  8547861531  
Fax    
Email  r.arunchand.89@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Anurakshat Gupta 
Designation  Associate Professor 
Affiliation  Armed Forces Medical College 
Address  DEPARTMENT OF SURGERY ARMED FORCES MEDICAL COLLEGE PUNE

Pune
MAHARASHTRA
411040
India 
Phone  9453507975  
Fax    
Email  anurakshat@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Arunchand R 
Designation  Resident Surgery 
Affiliation  Armed Forces Medical College 
Address  Department of Surgery Armed Forces Medical College Pune

Pune
MAHARASHTRA
411040
India 
Phone  8547861531  
Fax    
Email  r.arunchand.89@gmail.com  
 
Source of Monetary or Material Support  
Armed Forces Medical College, Pune, Maharashtra 
 
Primary Sponsor  
Name  ARUNCHAND R 
Address  DEPARTMENT OF SURGERY ARMED FORCES MEDICAL COLLEGE PUNE 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
ARUNCHAND R  ARMED FORCES MEDICAL COLLEGE  Armed Forces Medical College PUNE MAHARASHTRA - 411040
Pune
MAHARASHTRA 
8547861531

r.arunchand.89@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
MEDICAL RESEARCH CELL & INSTITUTIONAL ETHICAL COMMITTEE, ARMED FORCES MEDICAL COLLEGE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N201||Calculus of ureter,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  SILODOSIN  SILODOSIN 8mg HS orally till expulsion of calculus or a maximum period of 30 days 
Comparator Agent  TAMSULOSIN  TAMSULOSIN 0.4mg HS orally till expulsion of calculus or maximum period of 30 days 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  a) Unilateral distal ureteric calculus
b) Size < 10 mm
c) Normal renal parameters (Serum Urea & Serum Creatinine)
d) Age 18-60 yrs 
 
ExclusionCriteria 
Details  a) Single kidney
b) Bilateral ureteric stone
c) Mid/upper ureteric calculus
d) Renal impairment
e) High grade hydroureteronephrosis (Grade III & IV as per Society of Fetal Ultrasound, SFU)
f) Any h/o previous endoscopic/ surgical/ ESWL interventions
g) Intolerable side-effects (Hypotension) to either tamsulosin/ silodosin
h) Evidence of UTI
j) Concomitant kidney/bladder stones
k) Patients already on any alpha blocker for BPH 
 
Method of Generating Random Sequence   Permuted block randomization, fixed 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
STONE CLEARENCE RATE (%)  1. Passing of stone
2. 04 weeks elapsed and surgical intervention planned
3. Symptoms of patient demanding interventional procedures 
 
Secondary Outcome  
Outcome  TimePoints 
STONE EXPULSION TIME (DAYS)  1. Passing of stone
2. 04 weeks elapsed and surgical intervention planned
3. Symptoms of patient demanding interventional procedures 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   01/07/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   70% ureteric calculus are situated in lower 1/3rd of ureter, referred as Distal Ureteric Stones (DUS). Medical Expulsion Therapy(MET) has replaced minimally invasive procedures due to incidence of major complications including ureteric avulsions, perforation & strictures in the latter.
Uroselective Alfa adrenergic blockers as MET has been accepted as first line management of small lower ureteric calculus as various meta analysis shows stone passage of 44% - 52%. However MET has been associated with side effects including retrograde ejaculation.
Identification of Î±1A adrenoreceptor blocker capable of lesser side effects has been proposed as an alternative to Î±1 adreno receptor blocker.
The objective of study is to compare efficiecy of Tamsulosin vs Silodosin as MET of DUS in terms of stone clearence rate and stone expulsion time.
Randomisation will be achived by Block Randomisation and results are to be compared with appropriate statistical software.
 
Close